Cellectis Layoffs 2026
Healthcare & Pharma / Biotech · in vivo pivot · Nov 12 · Source: BioSpace / Fierce Biotech
Read original source (BioSpace / Fierce Biotech) →
Cellectis announced layoffs of 160 employees on November 12, 2026. Cellectis is cutting up to 70 percent of its staff as it drops allogeneic CAR T cell therapies for in vivo gene editing. The company has stopped enrollment in both of its CAR T programs.
$LAYOFF
The layoffhedge token. Listed on Coinbase.
View $LAYOFF on Coinbase →
$LAYOFF is a cryptocurrency. This is not financial advice. All investments carry risk. Do your own research.
← Back to the full 2026 layoff tracker